GALLI, Ubaldina
 Distribuzione geografica
Continente #
EU - Europa 2.736
NA - Nord America 2.309
AS - Asia 1.562
SA - Sud America 232
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.882
Nazione #
US - Stati Uniti d'America 2.236
RU - Federazione Russa 606
IE - Irlanda 499
SG - Singapore 426
CN - Cina 416
IT - Italia 387
DE - Germania 342
SE - Svezia 287
VN - Vietnam 206
HK - Hong Kong 196
UA - Ucraina 188
BR - Brasile 165
FR - Francia 127
FI - Finlandia 114
IN - India 114
GB - Regno Unito 63
TR - Turchia 59
CA - Canada 51
BD - Bangladesh 26
PL - Polonia 23
AR - Argentina 21
EE - Estonia 19
BE - Belgio 18
CZ - Repubblica Ceca 17
IR - Iran 17
ID - Indonesia 16
JP - Giappone 16
MX - Messico 16
ZA - Sudafrica 15
KR - Corea 12
PK - Pakistan 11
ES - Italia 10
IQ - Iraq 10
LT - Lituania 10
CL - Cile 8
CO - Colombia 8
PH - Filippine 8
VE - Venezuela 8
AT - Austria 7
EC - Ecuador 7
PE - Perù 6
NL - Olanda 5
SA - Arabia Saudita 5
BJ - Benin 4
DZ - Algeria 4
PY - Paraguay 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
GA - Gabon 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
EG - Egitto 2
EU - Europa 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
MD - Moldavia 1
NE - Niger 1
NO - Norvegia 1
NP - Nepal 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 6.882
Città #
Dublin 499
Jacksonville 360
Hong Kong 195
Dearborn 171
Singapore 141
San Jose 138
Beijing 136
Ashburn 122
Chandler 119
Ann Arbor 109
Piemonte 109
Wilmington 86
Moscow 75
Lawrence 63
Princeton 63
Ho Chi Minh City 59
Lauterbourg 56
Los Angeles 56
Hanoi 52
Munich 40
San Mateo 38
Andover 37
Bremen 32
New York 29
Santa Clara 29
Buffalo 26
São Paulo 24
Toronto 24
Ankara 23
Frankfurt am Main 22
Nanjing 21
Kecioeren 20
Milan 20
Redondo Beach 20
Helsinki 19
Orem 19
Dallas 18
Warsaw 18
Brno 16
Brussels 15
Novara 15
Hefei 14
Tokyo 13
Turku 13
Guangzhou 12
Houston 12
Johannesburg 12
Montreal 12
Nuremberg 12
Seoul 12
Strasbourg 12
Woodbridge 12
Formigine 11
Haiphong 11
Jinan 11
Kocaeli 11
Leawood 11
Turin 11
Chennai 10
Dong Ket 10
Chicago 9
Da Nang 9
Fairfield 9
Kaunas 9
Monmouth Junction 9
Poplar 9
Brooklyn 8
Denver 8
Hangzhou 8
Kunming 8
Varallo 8
Boardman 7
Manchester 7
Norwalk 7
Paris 7
Zanjan 7
Atlanta 6
Bexley 6
Boston 6
Calvisano 6
Council Bluffs 6
Düsseldorf 6
Hillsboro 6
Nanchang 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Albano Laziale 5
Annapolis 5
Berlin 5
Falkenstein 5
Grignasco 5
Guayaquil 5
Mexico City 5
Padua 5
Phoenix 5
Seattle 5
The Dalles 5
Belo Horizonte 4
Cambridge 4
Totale 3.614
Nome #
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 187
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 171
Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 166
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 165
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 161
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 158
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 158
Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction 150
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 147
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 136
Combretabenzodiazepines: a novel class of antitubulin agents 135
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. 131
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. 129
Characterization of NAD uptake in mammalian cells 126
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 126
Nicotinamide phosphoribosyltransferase (NAMPT) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH): interaction between moonlighting proteins as new molecular basis of cancer 121
The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors 121
Reaction Between (Z)-Arylchlorooximes and alpha-Isocyanoacetamides: a Procedure For The Synthesis of Aryl-alpha-Ketoamide amides 120
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 118
Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases 118
Biochemical and structural analysis of a cytosolic sulfotransferase of the malaria vector Anopheles gambiae overexpressed in the reproductive tissues 113
A fast route for the synthesis of tetrazolyl oximes by a novel multicomponent reaction between Z-chlorooximes, isocyanides and trimethylsilyl azide 113
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 113
Aryl Azides as Forgotten Electrophiles in the Van Leusen Reaction: A Multicomponent Transformation Affording 4-Tosyl-1-arylimidazoles 112
Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase 111
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage 107
Study of Anopheles gambiae 3-hydroxykynurenine transaminase activity and inhibition by LC-MS/MS method 107
A new furoxan NO-donor rabeprazole derivative and related compounds 105
Exploiting the Nucleophilicity of the Nitrogen Atom of Imidazoles: One-Pot Three-Component Synthesis of Imidazo-Pyrazines 104
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 103
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 103
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry 102
“Characterization of nicotinamide phosphoribosyltransferase inhibitors as anticancer agents” 101
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 101
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 101
CTLA-4 rs231775 and risk of acute renal graft rejection: an updated meta-analysis with trial sequential analysis 101
Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2 100
A Successful Replacement of Phenols with Isocyanides in the Bargellini Reaction: Synthesis of 3-Carboxamido-Isobutyric Acids 98
Gene polymorphisms and risk of acute renal graft rejection: a field synopsis of meta-analyses and genome-wide association studies 94
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 93
Unsimmetrically substituted furoxan. Part 16. Reaction of benzenesulfonyl substituted furoxans with ethanol and ethanethiol in basic medium. 93
Nicotinamide Phosphorybosyltransferase (NAMPT) Inhibitors are Novel Modulator of Cancer-Related Inflammation 90
Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists? 87
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 86
"Progettazione e sintesi di derivati furossanici solubili come profarmaci dell'ossido di azoto" 84
“Nicotinamide phosphoribosyl transferase (Nampt) inhibitors as antitumoral agents” 84
“Synthesis and in vitro evaluation of tetrasubstituted pyridines as potential PI3Ks inhibitors” 84
“Synthesis and biological evaluation of triazole analogues of FK866, a potent inhibitor of human Nicotinamide Phosphoribosyltransferase” 83
Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds 80
“Discovery of a nanomolar inhibitor of NMPRTase by Click Chemistry” 79
“Identification of the first selective Sirt3 inhibitor”, 79
Water Soluble Furoxan Derivatives as NO Prodrugs 78
“Antisecretory and Gastroprotective Activities of a Nitric Oxide (NO)-Releasing Derivative of the Proton Pump Inhibitor Rabeprazole” 78
null 77
“A New Furoxan NO-donor Rabeprazole Derivative and Related Compounds” 74
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 73
Multicomponent reaction between (Z)-chloroximes, isocyanides and NH-heterocyclic rings 73
“Water Soluble Furoxan Derivetives as NO Prodrugs” 72
“Visfatin: new role as cytokine in tumour microenviroment” 72
“Sirtuins, new potential targets for HIV-therapy” 71
“Characterization of lipopeptide biosurfactants produced by Bacillus Licheniformis having anti-adhesion activity against pathogenic micro-organism”, 68
“Synthesis and biological evaluation of analogues of FK866, a potent inhibitor of human NMPRTase, a crucial enzyme in the salvage pathway of NAD+ biosynthesis”, 67
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 65
“Nicotinamide phosphoribosyltransferase (Nampt) inhibitors as anti-cancer agents in neuroblastoma” 65
α-Amino Acids as Synthons in the Ugi-5-Centers-4-Components Reaction: Chemistry and Applications 56
Synthesis and characterization of bis-triazolyl-pyridine derivatives as noncanonical dna-interacting compounds 55
An adamantane-based ligand as a novel chemical tool for thermosensory TRPM8 channel therapeutic modulation 42
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy 38
Totale 6.979
Categoria #
all - tutte 34.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 30 70 16
2021/2022483 36 9 47 55 28 3 43 8 32 29 60 133
2022/20231.162 73 49 61 20 88 117 51 72 542 6 41 42
2023/2024320 33 24 43 18 54 0 67 6 4 0 19 52
2024/2025771 19 14 55 12 18 64 76 62 182 89 29 151
2025/20262.421 125 89 192 415 281 177 268 495 187 192 0 0
Totale 6.979